Engineering Microfluidic Systems for Low-Input Multi-Omic Profiling of Brain Regulatory States

dc.contributor.authorHadlock, Thomas Moniotteen
dc.contributor.committeechairLu, Changen
dc.contributor.committeememberDucker, William A.en
dc.contributor.committeememberWrenn, Steven Parkeren
dc.contributor.committeememberGoldstein, Aaron S.en
dc.contributor.departmentChemical Engineeringen
dc.date.accessioned2026-04-01T08:00:25Zen
dc.date.available2026-04-01T08:00:25Zen
dc.date.issued2026-03-31en
dc.description.abstractMicrofluidic systems enable sensitive application of sequencing based "omic" assays to rare sample sets. In this thesis, we developed and applied these systems to address fundamental limitations in existing assays and to investigate biological questions that are inaccessible using traditional bulk protocols. First, we introduced a microfluidic platform for rapid field-ready library preparation of viral samples for nanopore sequencing. Our microreactor enabled laboratory independent viral diagnostics of field-collected Senecavalley virus A samples with accuracy in-line with gold standard RT-PCR assays. Additionally, our system enabled real-time mutation identification, detecting two high-confidence consensus single nucleotide variants within the SVA positive cohort. We then applied microfluidic MOWChIP platform to two epigenomic investigations into the effects of psilocybin on mouse cortical and subcortical regions. First, we examined the sex-specific enhancer alterations following psilocybin exposure in neurons extracted from the frontal cortex and nucleus accumbens to elucidate therapeutic mechanisms for combating opioid use disorder. Here we describe localized increases in enhancer activity in the mesolimbic nucleus accumbens compared to the frontal cortex. Additionally, we demonstrate significant recovery of key enhancer linked gene pathways disrupted by prolonged opioid use following acute psilocybin exposure in male mice absent in female cohort. Finally, we investigated epigenetic inheritance of prolonged psilocybin exposure in prenatal dams on their offspring. We uncover significant transcription factor regulatory network disruptions that persist through to the F1 generation. Specifically, reduction in regulatory efficacy of Egr2 and JunB transcription factors of which direct psilocybin exposure mediates significant expressional increases in the prefrontal cortex. We further uncover a sex specific nature of these alterations, in which minimized reach of early gene Egr2 is found primarily in female offspring following maternal exposure. These multi-omic investigations uncover significant sex-specific implications of psilocybin exposure on brain epigenome.en
dc.description.abstractgeneralMicrofludic devices allow for miniaturization of traditional laboratory techniques into closed, automatable systems that enable downscaling of initial input requirements. Among its various uses, the compact single pot nature of microfluidic systems removes requirements around large, immobile equipment anchoring sample handing and assay protocols from traditional laboratory environments. As a demonstration of these benefits, we begin this thesis with the development of a field-deployable microfluidic platform that enables preparation of nanopore sequencing libraries from viral samples. This portable system enables rapid viral pathogen diagnostics and variant monitoring at the point-of-care. We demonstrated the efficacy of this platform using the swine pathogen Senecavalley virus A, from which our system successfully diagnosed all 7 of our patient samples and 3 healthy controls. Additionally, our microreactor platform distinguished itself from gold-standard RT-PCR assays by identifying 2 single nucleotide variations within our patient cohort while simultaneously generating diagnostic calls. We then turned our attention to application of microfluidic devices to biological investigations of rare cell types within the mouse brain affected by psychedelic exposure made possible by their significantly reduced input requirements. Previous research on psychedelic compounds has demonstrated unique abilities to alter cell-signaling within the brain. These studies have shown psychedelic exposure leads to increased synaptic plasticity and dendritic density leading to gains in cognitive function. These neurogenic mechanisms may underly observed therapeutic qualities in treating myriad psychological disorders including PTSD, as well as driving positive behavioral changes associated with addiction and drug seeking behavior. Previous work in our lab has shown that these gains are accompanied by long-lasting epigenomic alterations in brain regions responsible for high-order executive function. We thus carried out two studies to better understand the epigenetic alterations associated with psychedelic exposure within these critical brain regions. First, we performed the first ever sex-specific investigation into the epigenomic changes associated with psilocybin exposure and its associated recovery in opioid addicted mice, probing brain regions driving drug seeking behavior. Our study found that psilocybin effectively recovered significant epigenomic alterations induced by prolonged opioid use, with observed recovery far more prevalent in males than in females. We then performed a study into epigenomic alterations inherited in offspring of females following prolonged psilocybin exposure to observe inherited marks escaping epigenetic reprograming. This study showed that maternal psilocybin exposure minimizes the regulatory impact of several key transcription factors driving the positive neurogenic properties of primary psychedelic exposure. Thus, downstream effects of increased expression of these key transcription factors are reduced in offspring. We also found these regulatory network minimizations to be localized within female offspring populations, potentially decreasing the efficacy of psychedelic therapeutics within these mice in the future.en
dc.description.degreeDoctor of Philosophyen
dc.format.mediumETDen
dc.identifier.othervt_gsexam:45726en
dc.identifier.urihttps://hdl.handle.net/10919/142528en
dc.language.isoenen
dc.publisherVirginia Techen
dc.rightsIn Copyrighten
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subjectMicrofluidicsen
dc.subjectEpigenomicsen
dc.subjectTranscriptomicsen
dc.subjectGenomicsen
dc.subjectDiagnosticsen
dc.titleEngineering Microfluidic Systems for Low-Input Multi-Omic Profiling of Brain Regulatory Statesen
dc.typeDissertationen
thesis.degree.disciplineChemical Engineeringen
thesis.degree.grantorVirginia Polytechnic Institute and State Universityen
thesis.degree.leveldoctoralen
thesis.degree.nameDoctor of Philosophyen

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Hadlock_TM_D_2026.pdf
Size:
4.46 MB
Format:
Adobe Portable Document Format